(Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors
US6818651B2 · kind B2 · utility
10Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 21, 2003 |
| Grant date | Nov 16, 2004 |
| Priority date | — |
| Expiry date | Aug 21, 2023 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
3,4-Dihydroisoquinoline and isoquinoline compounds of formula I, in which Ar represents a phenyl raidcal of the formulae IIa, IIb or IIc are novel effective PDE7 inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.